AXA/2025/FY/Earnings presentation: Difference between revisions

Content deleted Content added
PlumBot: publish from draft
PlumBot: publish from draft
Line 17:
== Front matter ==
 
=== Full Year 2025 earningsEarnings presentationPresentation ===
 
* '''AXAPresentation Full Year 2025date''' earnings presentation delivered on February 26, 2026 <sup>p. 1</sup>
 
=== IMPORTANTLEGALINFORMATIONANDCAUTIONARYSTATEMENTSCONCERNINGFORWARD-LOOKINGSTATEMENTSANDTHEUSEOF NON-GAAPFINANCIALMEASURES ===
=== Important legal information and cautionary statements concerning forward-looking statements and the use of non-GAAP financial measures ===
 
* '''Forward-looking statements''' include predictions of future events, trends, plans, expectations, or objectives, specifically expected underlying earnings per share (UEPS) growth for 2026 provided as one-off guidance for the final year of the Group's strategic plan <sup>p. 2</sup>.
* '''One-offRisk guidancefactors''' isand provideduncertainties inthat thismay presentationaffect regardingAXA's expectedbusiness underlyingare earningsdescribed perin sharePart (UEPS)5 growthof forAXA's 2026Universal inRegistration theDocument context offor the last year of the Group'sended currentDecember strategic31, plan2024 <sup>p. 2</sup>.
* '''RiskNon-GAAP factorsmeasures''' and uncertaintiesalternative thatperformance maymeasures affect(APMs) AXA'sused businessinclude are"Underlying describedearnings", in Part 5UEPS, "Riskunderlying Factorsreturn andon Riskequity", Management"combined ofratio", AXA'sand 2024"debt Universal Registration Documentgearing" <sup>p. 2</sup>.
* '''APM reconciliations''' are provided in AXA's Activity Report as of December 31, 2025, available on www.axa.com <sup>p. 2</sup>.
* '''Alternative performance measures''' (APMs) used include "Underlying earnings", UEPS ("underlying earnings per share"), "underlying return on equity", "combined ratio", and "debt gearing" <sup>p. 2</sup>.
* '''Financial statements''' for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026, and are subject to completion of an audit procedure by statutory auditorscompletion <sup>p. 2</sup>.
 
=== Table of contents ===
 
* '''FY25 Highlights''' presented by Thomas Buberl, Group CEO [<sup>p. 3; p.04]</sup>
* '''FY25 Business Performance''' presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology [<sup>p. 3; p.09]</sup>
* '''FY25 Financial Performance''' presented by Alban de Mailly Nesle, Group CFO [<sup>p. 3; p.13]</sup>
 
== FY25 Highlights ==
 
* '''Section dividertitle''': for "1 FY25 Highlights" presented by Thomas Buberl, Group CEO <sup>p. 4</sup>.
 
=== Full Year 2025 | Excellent performance ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Key financial highlights, FY25 <sup>p. 5</sup>
! style="text-align:left" | Metric
! class="col-ms" style="text-align:right" | Value
! class="col-s" style="text-align:right" | Change vs. FY24
|-
| style="text-align:left" | Revenues
| class="col-m" style="text-align:right" | +6% vs. FY24
| style="text-align:right" | +6%
|-
| style="text-align:left" | Underlying EPS
| class="col-m" style="text-align:right" | +8% vs. FY24
| style="text-align:right" | +8%
|-
| style="text-align:left" | Return on equity
| class="col-m" style="text-align:right" | 16%
| style="text-align:right" | —
|-
| style="text-align:left" | Solvency II ratio
| class="col-m" style="text-align:right" | 224%
| style="text-align:right" | —
|-
| style="text-align:left" | Shareholder value
| class="col-m" style="text-align:right" | +8% DPS growth and EUR 1.25bn annual share buyback
|-
| style="text-align:left" | Growth outlook
| class="col-m" style="text-align:right" | Confident to deliver underlying EPS growth at the upper end of the 6%-8% target range for 2026
|}
</div>
* Shareholder value delivered via +8% DPS growth and EUR 1.25bn annual share buyback
** Dividend proposal based on Board of Directors' recommendation on February 25, 2026, subject to approval at the Shareholders' Annual General Meeting on April 30, 2026
** Share buyback approved by the Board of Directors on February 25, 2026, expected to commence as soon as reasonably practicable, subject to market conditions
* Underlying EPS growth target for 2026 expected at the upper end of the 6%-8% range
 
=== Executing the plan on growth, margin and efficiency ===
Line 71 ⟶ 74:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings and growth, FY24 vs FY25 <sup>p. 6</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
Line 85 ⟶ 88:
|}
</div>
* TopHigh lineorganic growth of +6% LFLtop line growth, well balanced across lines: P&C +5%, Life +9%, Health +5%
* Record profitability driven by further margin expansion in P&C and L&H, alongside improvement in efficiency
* Scaling the business through continued investments in growth and technology
* EarningsConsistent earnings growth remains consistent while enhancing reserve prudence
 
=== Diversified franchise, well positioned in an attractive industry ===
 
* '''Secular trends''' fuel demand across businesses, driven by protection gaps and emerging corporate risks alongside demographics driving demand for private retirement and healthcare <sup>p. 7</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Business mix based on FY25 gross written premium split <sup>p. 7</sup>
! style="text-align:left" | Business mix
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Share
|-
Line 114 ⟶ 117:
|}
</div>
 
* '''Our right to win''' is supported by four strategic pillars:
* '''Secular trends''' are fueling demand across businesses, driven by protection gaps, emerging corporate risks, and demographics driving demand for private retirement and healthcare.
** Leading brand & high customer NPS <sup>p. 7</sup>
* '''Our right to win''' is supported by four key pillars:
** Strong and diversified distribution <sup>p. 7</sup>
** Leading brand & high customer NPS
** Technical expertise to price & underwrite risks <sup>p. 7</sup>
** Strong and diversified distribution
** Scale offering cost advantage <sup>p. 7</sup>
** Technical expertise to price & underwrite risks
* (donut) '''Business mix''' by FY25 gross written premium split (excluding AXA IM and holdings):
** Scale offering cost advantage
 
=== Laying the foundation for the next plan ===
Line 128 ⟶ 132:
** '''Enhancing capital allocation''' discipline <sup>p. 8</sup>
** '''Building resilience''' <sup>p. 8</sup>
* '''Earnings growth outlook''' outlook supported by strongthese pillars, providing confidence in sustaining performanceearnings growth <sup>p. 8</sup>.
 
=== FY25 Business Performance ===
 
* '''Section 2divider''' for Part 2: "FY25 Business Performance," presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 9</sup>.
 
== FY25 Business Performance ==
 
=== Strong delivery across our businesses ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Gross written premiums and underlying earnings by region <sup>p. 10</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-ms" style="text-align:right" | % of total GWP
! class="col-ms" style="text-align:right" | Gross written premiumsGWP
! class="col-ms" style="text-align:right" | UnderlyingGWP earningschange
! class="col-s" style="text-align:right" | Underlying earnings
! class="col-s" style="text-align:right" | Underlying earnings change
|-
| style="text-align:left" | France
| class="col-m" style="text-align:right" | 27%
| class="col-m" style="text-align:right" | 31 (+6% LFL)
| class="col-m" style="text-align:right" | 2.2 (+76% LFL)
| style="text-align:right" | 2.2
| style="text-align:right" | +7%
|-
| style="text-align:left" | Europe
| class="col-m" style="text-align:right" | 38%
| class="col-m" style="text-align:right" | 43 (+6% LFL)
| class="col-m" style="text-align:right" | 3.5 (+96% LFL)
| style="text-align:right" | 3.5
| style="text-align:right" | +9%
|-
| style="text-align:left" | AXA XL
| class="col-m" style="text-align:right" | 17%
| class="col-m" style="text-align:right" | 19 (+4% LFL)
| class="col-m" style="text-align:right" | 1.9 (+94% LFL)
| style="text-align:right" | 1.9
| style="text-align:right" | +9%
|-
| style="text-align:left" | Asia, Africa & EME-LATAM
| class="col-m" style="text-align:right" | 18%
| class="col-m" style="text-align:right" | 20 (+13% LFL)
| class="col-m" style="text-align:right" | 1.5 (+613% LFL)
| style="text-align:right" | 1.5
| style="text-align:right" | +6%
|}
</div>
 
* '''Gross written premiums''' change is at constant scope and FX
* '''Underlying earnings''' change is at constant FX
* '''Total GWP''' basis excludes AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers for FY25 gross written premiums
 
=== P&C | Strong margins, confidence in sustaining growth ===
 
<div style="overflow-x:auto">
* '''Underlying earnings''' +9% LFL to EUR 5.9bn <sup>p. 11</sup>.
{| class="wikitable fintable"
* (pie) '''GWP mix''': EUR 58bn total GWP, split across Retail, SME & Mid-market, and AXA XL (Large & Specialty) <sup>p. 11</sup>.
** '''AXA XL'''|+ GWP includes AXA XL Re premiums of EUR 2.6bnmix <sup>p. 11</sup>.
! style="text-align:left" | Segment
* (diagram) '''Strategic roadmap''':
! class="col-s" style="text-align:right" | Share
** '''Retail and SME & Mid-market''':
|-
*** '''2025''': Growing volumes while expanding margins <sup>p. 11</sup>.
| style="text-align:left" | Retail
*** '''Beyond 2025''': Investing to improve customer retention and expanding distribution footprint <sup>p. 11</sup>.
| style="text-align:right" | 34%
** '''AXA XL (Large & Specialty)''':
|-
*** '''2025''': Profitable growth with stable margins <sup>p. 11</sup>.
| style="text-align:left" | AXA XL (Large & Specialty)
*** '''Beyond 2025''': Capitalizing on attractive growth opportunities and continued cycle management <sup>p. 11</sup>.
| style="text-align:right" | 33%
** '''Enablers''': Continued progress on efficiency, higher investment income, and data & AI to further enhance customer experience and technical excellence <sup>p. 11</sup>.
|-
| style="text-align:left" | SME & Mid-market
| style="text-align:right" | 33%
|}
</div>
 
* '''Underlying earnings''' +9% LFL to EUR 5.9bn
=== L&H | Good momentum, well positioned to capture growth opportunities ===
* '''AXA XL''' includes AXA XL Re premiums of EUR 2.6bn
* '''Retail and SME & Mid-market''' strategic outlook:
** '''2025''': Growing volumes while expanding margins
** '''Beyond 2025''': Investing to improve customer retention and expanding distribution footprint
* '''AXA XL (Large & Specialty)''' strategic outlook:
** '''2025''': Profitable growth with stable margins
** '''Beyond 2025''': Capitalizing on attractive growth opportunities and continued cycle management
* '''Growth enablers''':
** Continued progress on efficiency
** Higher investment income
** Data & AI to further enhance customer experience and technical excellence
* (pie) '''GWP mix''': EUR 58bn total GWP, split across Retail, AXA XL (Large & Specialty), and SME & Mid-market <sup>p. 11</sup>
 
=== L&H| Good momentum, well positioned to capture growth opportunities ===
* (pie) '''GWP mix''': EUR 57bn total GWP, split between Long-term and Short-term business <sup>p. 12</sup>
 
* '''Underlying earnings''' +7% LFL to EUR 3.5bn (reported change at constant FX) <sup>p. 12</sup>
<div style="overflow-x:auto">
* '''Long-term business''' strategic priorities:
{| class="wikitable"
|+ GWP mix <sup>p. 12</sup>
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Share
|-
| style="text-align:left" | Long-term
| class="col-s" style="text-align:right" | Majority
|-
| style="text-align:left" | Short-term
| class="col-s" style="text-align:right" | Minority
|}
</div>
 
* Underlying earnings +7% LFL to EUR 3.5bn <sup>p. 12</sup>
* '''Long-term business''' strategic outlook:
** '''2025''': Accelerating net flows in Savings at attractive margins <sup>p. 12</sup>
** '''Beyond 2025''': Capturing savings & retirement opportunity, sourcing best asset management products for our customers <sup>p. 12</sup>
* '''Short-term business''' strategic prioritiesoutlook:
** '''2025''': Growing technical results while absorbing Mexico VAT impact <sup>p. 12</sup>
** '''Beyond 2025''': Capitalizing on demand for health & protection while further improving our margins <sup>p. 12</sup>
Line 193 ⟶ 246:
** Increasing penetration of Protection riders in Savings offerings <sup>p. 12</sup>
** Leveraging AI to reduce claims leakage & improve customer outcomes in Health <sup>p. 12</sup>
* (pie) '''GWP mix''': EUR 57bn total, split between Long-term (majority) and Short-term <sup>p. 12</sup>
 
=== FY25 Financial Performance ===
 
* '''Section title3''': FY25 Financial Performance presented by Alban de Mailly Nesle, Group CFO <sup>p. 13</sup>
* '''Presenter''': Alban de Mailly Nesle, Group CFO <sup>p. 13</sup>
 
=== P&C | Continued disciplined growth ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ GWP & other revenues by line, FY24 vs FY25segment <sup>p. 14</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
Line 241 ⟶ 294:
</div>
 
* '''Commercial lines growth''' driven by continuedContinued pricing momentum and volume growth in Mid-market and SME <sup>p. 14</sup>.
* '''AXA XL Insurance''' strategy focused on growingGrowing in lines of business with attractive margins while remaining focused on retention at AXA XL Insurance <sup>p. 14</sup>.
* '''AXA XL Reinsurance''' growthGrowth supported by alternative capital <sup>p. 14</sup>.
* '''Retail lines growth''' supported by favorableFavorable pricing trends and strong growth in net new contracts with +1.7m in FY25 <sup>p. 14</sup>.
 
=== P&C | Delivering further margin expansion while enhancing reserve prudence ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Combined ratio components, FY24 vs FY25 <sup>p. 15</sup>
! style="text-align:left" | %
! class="col-s" style="text-align:right" | FY24
Line 277 ⟶ 330:
</div>
 
* '''Combined ratio''' improved to 90.6% (prior: 91.0%) <sup>p. 15</sup>
* '''Undiscounted current yearCY loss ratio''' excluding Nat Cat improved, driven byfrom:
** Margin expansion in Commercial lines SME & mid-market business and Personal lines reflecting a favorable pricing environment <sup>p. 15</sup>
** Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management <sup>p. 15</sup>
* '''Expense ratio''' improved reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology <sup>p. 15</sup>
* '''Nat Cat charges''' remained below normalized load <sup>p. 15</sup>
* '''Prior year reserve development''' reliance was lower, taking advantage of a good year to enhance reserve prudence <sup>p. 15</sup>
 
=== P&C | Earnings growth from higher underwriting and financial result ===
 
<div style="overflow-x:auto">
Line 296 ⟶ 349:
| style="text-align:right" | 5,510
|-
| style="text-align:left" | Underwriting result (Volume growth)
| style="text-align:right" | +292
|-
| style="text-align:left" | Underwriting result (Margin improvement)
| style="text-align:right" | +189
|-
| style="text-align:left" | Financial result (Investment income)
| style="text-align:right" | +435
|-
| style="text-align:left" | Financial result (Insurance finance expenses)
| style="text-align:right" | -235
|-
Line 318 ⟶ 371:
|}
</div>
 
* Underlying earnings grew +9% at constant FX.
* '''Underlying earnings''' grew +9% at constant FX to EUR 5,872m.
* Underwriting result improved from strong volume growth and improved all-year combined ratio while enhancing reserve prudence.
* '''Underwriting result''' improved from strong volume growth and improved all-year combined ratio while enhancing reserve prudence.
* Investment income increased reflecting higher volumes and better reinvestment yields on fixed income assets.
* '''Investment income''' increased reflecting higher volumes and better reinvestment yields on fixed income assets.
* Insurance finance expenses impacted by higher unwind of discount of claims reserves, in line with guidance.
* '''Insurance finance expenses''' impacted by higher unwind of discount of claims reserves, in line with guidance.
* Forex impact was unfavorable, notably due to USD depreciation vs. EUR.
* '''Forex impact''' was unfavorable, notably due to USD depreciation vs. EUR.
 
=== Life & Health | Strong growth in premiums, positive net flows ===
Line 328 ⟶ 382:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Life GWP & other revenues and Net flows, FY24 vs FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Changechange
! class="col-s" style="text-align:right" | Net flows FY25
|-
| style="text-align:left" | '''Life GWP & other revenues'''
| style="text-align:right" | 34.5
| style="text-align:right" | 37.5
| style="text-align:right" | +9%
| style="text-align:right" | —
|-
| style="text-align:left" | Protection
Line 345 ⟶ 392:
| style="text-align:right" | 17.3
| style="text-align:right" | +11%
| style="text-align:right" | +4.9
|-
| style="text-align:left" | Unit-linked
Line 351 ⟶ 397:
| style="text-align:right" | 9.3
| style="text-align:right" | +13%
| style="text-align:right" | +1.5
|-
| style="text-align:left" | Capital light G/A
Line 357 ⟶ 402:
| style="text-align:right" | 9.0
| style="text-align:right" | +7%
| style="text-align:right" | +1.2
|-
| style="text-align:left" | Traditional G/A
Line 363 ⟶ 407:
| style="text-align:right" | 1.9
| style="text-align:right" | -7%
| style="text-align:right" | -5.0
|-
| style="text-align:left; font-weight:bold" | Employee BenefitsTotal
| style="text-align:right; font-weight:bold" | 34.5
| style="text-align:right; font-weight:bold" | 1237.95
| style="text-align:right; font-weight:bold" | +49%
|}
| style="text-align:right" | —
</div>
|-
 
| style="text-align:left" | '''Health GWP & other revenues'''
|<div style="textoverflow-alignx:rightauto" | 17.5>
{| class="wikitable fintable"
| style="text-align:right" | 19.0
|+ Health GWP & other revenues, FY24 vs FY25 <sup>p. 17</sup>
| style="text-align:right" | +5%
|! style="text-align:rightleft" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL change
|-
| style="text-align:left" | Individual
Line 381 ⟶ 427:
| style="text-align:right" | 10.5
| style="text-align:right" | +6%
| style="text-align:right" | —
|-
| style="text-align:left" | Group
Line 387 ⟶ 432:
| style="text-align:right" | 8.5
| style="text-align:right" | +4%
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | '''Total Net flows'''
| style="text-align:right; font-weight:bold" | 17.5
| style="text-align:right; font-weight:bold" | 19.0
| style="text-align:right; font-weight:bold" | +5%
|}
| style="text-align:right" | +5.4
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Net flows by segment, FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Net flows
|-
| style="text-align:left" | Protection
| style="text-align:right" | +4.9
|-
| style="text-align:left" | Health
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | +2.7
|-
| style="text-align:left" | Unit-linked
| style="text-align:right" | +1.5
|-
| style="text-align:left" | Capital light G/A
| style="text-align:right" | +1.2
|-
| style="text-align:left" | Traditional G/A
| style="text-align:right" | -5.0
|}
</div>
 
* Employee Benefits includes both short-term and long-term Employee Benefits GWP and other revenues.
* '''Employee Benefits''' GWP and other revenues (including both short-term and long-term) was EUR 12.9bn in FY25, up +4%.
* Net flows FY25: EUR +5.4bn (vs EUR +1.5bn in FY24).
* '''Net flows''' reached EUR +5.4bn (compared to EUR +1.5bn in FY24).
 
=== Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting ===
Line 413 ⟶ 474:
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Changechange
|-
| style="text-align:left" | '''PVEP'''
Line 449 ⟶ 510:
| style="text-align:right" | 2.2
| style="text-align:right" | stable
|-
| style="text-align:left" | NBV margin
| style="text-align:right" | 4.4%
| style="text-align:right" | 4.5%
| style="text-align:right" | —
|}
</div>
 
* PVEP impacted by higher interest rates on discounting despite strong growth in Life volumes.
* NB'''PVEP''' CSM driven by robust Savings & Protection sales; reported growthwas impacted by higher interest rates foron discounting ofdespite strong growth in futureLife profitsvolumes.
* '''NB CSM''' was driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits.
* NBV broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France.
* '''NBV''' was stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France.
* NBV margin: 4.4% in FY24 vs 4.5% in FY25.
 
=== Life & Health | Growth in new business driving Normalized CSM growth ===
Line 460 ⟶ 526:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Contractual Service Margin rollforward, FY24 to FY25 <sup>p. 19</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Contractual Service Margin
|-
| style="text-align:left" | FY24 starting value
| style="text-align:right" | 33.6
|-
Line 485 ⟶ 551:
| style="text-align:right" | -1.4
|-
| style="text-align:left" | FY25 ending value
| style="text-align:right" | 33.0
|}
</div>
 
* '''Normalized CSM''' up by +2% LFL, with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates <sup>p. 19</sup>.
* '''Economic variance''' reflecting government spreads tightening and positive equity market returns <sup>p. 19</sup>.
* '''Operating variance''' driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland <sup>p. 19</sup>.
* '''FX impact''' mainly from JPY and HKD depreciation <sup>p. 19</sup>.
* FY24 starting value: o/w Life: EUR 25.8bn, o/w Health: EUR 7.7bn <sup>p. 19</sup>
* CSM release: Normalized CSM growth +2%
* FY25: o/w Life: EUR 25.4bn, o/w Health: EUR 7.6bn <sup>p. 19</sup>
* FY25 ending value: o/w Life EUR 25.4bn, o/w Health EUR 7.6bn
 
=== Life & Health | Strong momentum in both short-term and long-term business ===
Line 501 ⟶ 568:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings bridge, FY24 to FY25 <sup>p. 20</sup>
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" | Underlying earnings
|-
| style="text-align:left" | FY24 start
| style="text-align:right" | 3,323
|-
Line 520 ⟶ 587:
| style="text-align:right" | -27
|-
| style="text-align:left" | FY25 end
| style="text-align:right" | 3,501
|}
</div>
 
* '''Underlying earnings''' increased +7% LFL to EUR 3,501m <sup>p.(reported: EUR 3,323m in 20</sup>.FY24)
* '''Short-term technical margin''': EUR 415m in FY24 to EUR 479m in FY25 <sup>p. 20</sup>.
* '''Long-term result''' incl. CSM release''': EUR 2,680m in FY24 to EUR 2,804m in FY25 <sup>p. 20</sup>.
* '''Financial result''': EUR 975m in FY24 to EUR 946m in FY25 <sup>p. 20</sup>.
* '''Tax & others''': -EUR -748m in FY24 to -EUR -728m in FY25 <sup>p. 20</sup>.
* '''Life segment''' underlyingcontribution: earningsEUR increased2.6bn in FY24 to EUR 2.7bn in FY25 (+4% vs. FY24; FY24 was EUR 2.6bn) <sup>p. 20</sup>.
* '''Health segment''' underlyingcontribution: earningsEUR increased0.7bn in FY24 to EUR 0.8bn in FY25 (+17% vs. FY24; FY24 was EUR 0.7bn) <sup>p. 20</sup>.
* '''Short-term technical margin''' strong, reflectingon underwriting and claims initiatives that; more than offset the impact of legislative change on theMexico VAT recoverability of value added tax in Mexico ofEUR -EUR 0.1bn <sup>p. 20</sup>.
* '''Long-term results''' higher from increase in CSM release (increase of +8%) reflecting growth inon reserve base growth, including from favorable equity market performancemarkets, and better margins <sup>p. 20</sup>.
 
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ===
Line 539 ⟶ 606:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Earnings and net income metrics <sup>p. 21</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24Prior year
! class="col-s" style="text-align:right" | FY25Current year
! class="col-s" style="text-align:right" | Change (at constant FX)
|-
| style="text-align:left" | Property & Casualty
Line 572 ⟶ 639:
| style="text-align:left" | Non-financial flows
| style="text-align:right" | -0.5
| style="text-align:right" | +2.1
| style="text-align:right" | —
|-
| style="text-align:left" | Capital gains from AXA IM disposal
| style="text-align:right" | —
| style="text-align:right" | 2.2
| style="text-align:right" | —
|-
| style="text-align:left" | Financial flows (incl.including RCG)
| style="text-align:right" | +0.3
| style="text-align:right" | -0.7
| style="text-align:right" | —
Line 594 ⟶ 656:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings per share (reported basis) <sup>p. 21</sup>
! style="text-align:left" | Euro unless otherwise mentionedEUR
! class="col-s" style="text-align:right" | FY24Value
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change (reported basis)
|-
| style="text-align:left" | UnderlyingPrior earnings per shareyear
| style="text-align:right" | 3.59
|-
| style="text-align:left" | Current year
| style="text-align:right" | 3.86
|-
| style="text-align:left" | Change
| style="text-align:right" | +8%
|-
| style="text-align:left" | Earnings growth contribution
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | +6%
|-
| style="text-align:left" | Capital management contribution
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | +3%
|-
| style="text-align:left" | Forex impact
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | -2%
|-
| style="text-align:left" | TemporaryDilution dilutionimpact
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | -1%
|}
</div>
 
* '''Underlying earnings''' driven by strong performance from insurance businesses <sup>p. 21</sup>
* '''HoldingHoldings cost& other''' cost stable, expected to remain at current level in 2026 <sup>p. 21</sup>
* '''Net income''' increase mainly reflects higher underlying earnings and the gain from the sale of AXA IM <sup>p. 21</sup>
* '''Non-financial flows''': Capital gains from AXA IM disposal: EUR +2.2bn (prior: nil)
* '''Financial flows''' lower, reflecting unfavorable forex impact <sup>p. 21</sup>
* '''Financial flows''' lower, reflecting unfavorable forex impact
* '''Temporary dilution''': includes -1% from temporary earnings dilution from AXA IM sale due to the timing of anti-dilutive share buyback <sup>p. 21</sup>
* '''Dilution''' impact: includes -1% from temporary earnings dilution from AXA IM sale due to the timing of the anti-dilutive share buyback
 
== FY25 Financial Performance ==
 
=== Shareholders' Equity ===
 
<div style="overflow-x:auto">
* '''Shareholders' equity''' (Group share) trends in EUR billion <sup>p. 22</sup>:
{| class="wikitable fintable"
** (stacked bar) '''Shareholders' equity''' (SHE):
|+ Shareholders' equity and related metrics <sup>p. 22</sup>
*** '''FY24''': EUR 49.9bn total (SHE excl. OCI: EUR 58.0bn; Net OCI: EUR -8.1bn) <sup>p. 22</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
*** '''HY25''': EUR 45.5bn total (SHE excl. OCI: EUR 52.7bn; Net OCI: EUR -7.2bn) <sup>p. 22</sup>
! class="col-s" style="text-align:right" | FY24
*** '''FY25''': EUR 47.2bn total (SHE excl. OCI: EUR 54.0bn; Net OCI: EUR -6.8bn) <sup>p. 22</sup>
! class="col-s" style="text-align:right" | HY25
** '''SHE (excl. OCI & undated subordinated debt)''': EUR 53.2bn in FY24 → EUR 47.0bn in HY25 → EUR 49.4bn in FY25 <sup>p. 22</sup>
! class="col-s" style="text-align:right" | FY25
** '''Debt gearing''': 20.6% in FY24 → 23.4% in HY25 → 22.3% in FY25 <sup>p. 22</sup>
|-
** '''Underlying ROE''': 15.2% in FY24 → 17.5% in HY25 → 16.0% in FY25 <sup>p. 22</sup>
*| style="text-align:left" | '''Shareholders' equity bridge''' (in EUR billion) <sup>p. 22</sup>:total
| style="text-align:right" | 49.9
** '''Opening Shareholders' equity''': EUR 49.9bn (FY24 to FY25) | EUR 45.5bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:right" | 45.5
** '''Change in Net OCI''': +EUR 1.3bn (FY24 to FY25) | +EUR 0.4bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:right" | 47.2
** '''Net income for the period''': +EUR 9.8bn (FY24 to FY25) | +EUR 5.9bn (HY25 to FY25) <sup>p. 22</sup>
|-
** '''Dividend''': -EUR 4.6bn (FY24 to FY25) | nil (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:left" | SHE excl. OCI
** '''Annual share buyback''': -EUR 1.2bn (FY24 to FY25) | nil (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:right" | 58.0
** '''Anti-dilutive share buyback''' following the sale of AXA IM: -EUR 3.5bn (FY24 to FY25) | -EUR 3.5bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:right" | 52.7
** '''Undated subordinated debt''' (including interest charges): -EUR 0.3bn (FY24 to FY25) | -EUR 1.2bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:right" | 54.0
** '''Forex''': -EUR 3.5bn (FY24 to FY25) | -EUR 0.1bn (HY25 to FY25) <sup>p. 22</sup>
|-
** '''Other''': -EUR 0.6bn (FY24 to FY25) | +EUR 0.3bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:left" | Net OCI
** '''Closing Shareholders' equity''': EUR 47.2bn (FY24 to FY25) | EUR 47.2bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:right" | -8.1
| style="text-align:right" | -7.2
| style="text-align:right" | -6.8
|-
| style="text-align:left" | SHE (excl. OCI & undated subordinated debt)
| style="text-align:right" | 53.2
| style="text-align:right" | 47.0
| style="text-align:right" | 49.4
|-
| style="text-align:left" | Debt gearing
| style="text-align:right" | 20.6%
| style="text-align:right" | 23.4%
| style="text-align:right" | 22.3%
|-
| style="text-align:left" | Underlying ROE
| style="text-align:right" | 15.2%
| style="text-align:right" | 17.5%
| style="text-align:right" | 16.0%
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Shareholders' equity bridge, FY24 to FY25 vs. HY25 to FY25 <sup>p. 22</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24 to FY25
! class="col-s" style="text-align:right" | HY25 to FY25
|-
| style="text-align:left" | Opening Shareholders' equity
| style="text-align:right" | 49.9
| style="text-align:right" | 45.5
|-
| style="text-align:left" | Change in Net OCI
| style="text-align:right" | +1.3
| style="text-align:right" | +0.4
|-
| style="text-align:left" | Net income for the period
| style="text-align:right" | +9.8
| style="text-align:right" | +5.9
|-
| style="text-align:left" | Dividend
| style="text-align:right" | -4.6
| style="text-align:right" | nil
|-
| style="text-align:left" | Annual share buyback
| style="text-align:right" | -1.2
| style="text-align:right" | nil
|-
| style="text-align:left" | Anti-dilutive share buyback following the sale of AXA IM
| style="text-align:right" | -3.5
| style="text-align:right" | -3.5
|-
| style="text-align:left" | Undated subordinated debt (including interest charges)
| style="text-align:right" | -0.3
| style="text-align:right" | -1.2
|-
| style="text-align:left" | Forex
| style="text-align:right" | -3.5
| style="text-align:right" | -0.1
|-
| style="text-align:left" | Other
| style="text-align:right" | -0.6
| style="text-align:right" | +0.3
|-
| style="text-align:left" | Closing Shareholders' equity
| style="text-align:right" | 47.2
| style="text-align:right" | 47.2
|}
</div>
* '''Shareholders' equity''' (Group share) reported in EUR billion <sup>p. 22</sup>.
 
=== Higher organic cash remittance and robust cash position at Holding ===
Line 659 ⟶ 788:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Net cash remittance and holdingHolding cash position bridge <sup>p. 23</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Net cash remittance total
| style="text-align:right" | 7.7
| style="text-align:right" | 7.5
|-
| style="text-align:left" | Ordinary remittance
Line 671 ⟶ 804:
| style="text-align:right" | 0.6
| style="text-align:right" | —
|-
| style="text-align:left" | '''Net cash remittance total'''
| style="text-align:right" | '''7.7'''
| style="text-align:right" | '''7.5'''
|-
| style="text-align:left" | Remittance ratio
Line 684 ⟶ 813:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Holding cash position bridge <sup>p. 23</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Holding cash positionValue
|-
| style="text-align:left" | FY24 cashCash position
| style="text-align:right" | 4.0
|-
Line 711 ⟶ 841:
| style="text-align:right" | +3.1
|-
| style="text-align:left" | FY25 cashCash position
| style="text-align:right" | 5.6
|}
Line 726 ⟶ 856:
! class="col-s" style="text-align:right" | Eligible Own Funds (EOF)
! class="col-s" style="text-align:right" | Solvency Capital Requirement (SCR)
! class="col-s" style="text-align:right" | Solvency II ratio (%pts)
|-
| style="text-align:left" | FY24
Line 769 ⟶ 899:
|}
</div>
 
* Solvency II ratio increased to 224% in FY25 (was 216% in FY24) <sup>p. 24</sup>.
* Dividend & annual share buyback includes foreseeable dividends of -EUR 4.8bn and provision for annual share buyback for 2026 of -EUR 1.25bn <sup>p. 24</sup>.
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Key sensitivities onof Solvency II ratio as of December 31, 2025 (Base: 224%) <sup>p. 24</sup>
! style="text-align:left" | Sensitivity
! class="col-s" style="text-align:right" | Change (pts)
Line 811 ⟶ 938:
</div>
 
* EuroDividend Sovereign& spreadsannual +50bps:share assumesbuyback 50bpsincludes spreadforeseeable wideningdividends of Euro-EUR sovereign4.8bn bondsand vs.provision Eurofor swapannual curveshare appliedbuyback onfor sovereign2026 andof quasi-sovereignEUR exposures1.25bn <sup>p. 24</sup>.
* Credit migration: assumes 20% of corporate bonds, including private debt, held are downgraded by one full letter / 3 notches <sup>p. 24</sup>
 
=== Solvency II -impact of the end of grandfathering period and Solvency II revision ===
Line 819 ⟶ 945:
{| class="wikitable fintable"
|+ Solvency II ratio and impacts <sup>p. 25</sup>
! style="text-align:left" | MetricSolvency II ratio (pts)
! class="col-s" style="text-align:right" | Value
|-
| style="text-align:left" | Solvency II ratio asAs of December 31, 2025
| style="text-align:right" | 224%
|-
| style="text-align:left" | Grandfathering end impact on January 1, 2026
| style="text-align:right" | -10pts10
|-
| style="text-align:left" | SolvencyRatio IIafter revisiongrandfathering impact (estimated for 1Q27)
| style="text-align:right" | +17pts215
|-
| style="text-align:left" | Solvency II revision impact (estimated)
| style="text-align:right" | +17
|}
</div>
* EUR 2.4bn of grandfathered debt is no longer eligible as capital from January 1, 2026.
 
* EUR 2.4bn grandfathered debt is no longer eligible as capital from January 1, 2026.
* No change is expected in organic capital generation.
* Provides additional capital flexibility.
* Revision impact is estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date.
* '''GrandfatheringSolvency endII impactrevision''' onimpact, Januaryexpected 1,to 2026come isinto -10pts,effect reducingin the1Q27, ratiois toestimated at 215%+17pts <sup>p. 25</sup>.
 
=== Thomas Buberl, Group CEO conclusionConclusion ===
 
* '''ConclusionSection divider''' presentedfor the conclusion presentation by Thomas Buberl, Group CEO <sup>p. 26</sup>.
 
=== Conclusion ===
 
* '''Record results''' achieved at the top end of the target range while enhancing reserve prudence <sup>p. 27</sup>.
* '''BusinessAll performancebusinesses''' shows all businesses in excellent shape, delivering strong growth and profitability <sup>p. 27</sup>.
* '''Diversified franchise''' is well-positioned to capture future growth opportunities <sup>p. 27</sup>.
* '''StrategicFuture outlook''' focused on laying foundations for the next plan and confident in delivering sustainable earnings growth <sup>p. 27</sup>.
 
=== February 26, 2026 Q&A Full Year 2025 earningsEarnings ===
 
* '''Q&A session''' for Full Year 2025 Earnings held on February 26, 2026 <sup>p. 28</sup>
Line 856 ⟶ 984:
=== AXA Investor Relations | Keep in touch ===
 
* '''Roadshows''': March in Europe and US <sup>p. 29</sup>
* '''1Q25 Activity Indicators''': May 5 in Paris <sup>p. 29</sup>
* '''BNP Paribas Exane''' CEO Conference: June 2 in Paris <sup>p. 29</sup>
* '''Goldman Sachs European''' Financials Conference: June 2-4 in Zurich <sup>p. 29</sup>
* '''HY26 Earnings Release''': July 31 in Paris <sup>p. 29</sup>
* '''AXA Investor Day''': September 21 in London <sup>p. 29</sup>
* '''Investor Relations contact''': +33 1 40 75 48 42; investor.relations@axa.com <sup>p. 29</sup>
* '''Follow us''': www.axa.com <sup>p. 29</sup>
* '''Financial calendar''':
** '''March''': Roadshows (Europe and US) <sup>p. 29</sup>
** '''May 5''': 1Q25 Activity Indicators (Paris) <sup>p. 29</sup>
** '''June 2''': BNP Paribas Exane CEO Conference (Paris) <sup>p. 29</sup>
** '''June 2-4''': Goldman Sachs European Financials Conference (Zurich) <sup>p. 29</sup>
** '''July 31''': HY26 Earnings Release (Paris) <sup>p. 29</sup>
** '''September 21''': AXA Investor Day (London) <sup>p. 29</sup>
 
== Appendices ==
Line 870 ⟶ 997:
* Section divider slide marking the beginning of the '''Appendices''' section <sup>p. 30</sup>.
 
=== Table of contents ===
* '''Debt and Invested Assets''' <sup>p. 31</sup>
 
* '''Additional P&C disclosures''' <sup>p. 36</sup>
* '''AdditionalTable IFRS17of disclosurescontents''' <sup>p.agenda 41</sup>structure:
** 1. '''SustainabilityDebt and Invested Assets''' <sup>p. 4431</sup>
** 2. Additional P&C disclosures <sup>p. 36</sup>
** 3. Additional IFRS17 disclosures <sup>p. 41</sup>
** 4. Sustainability <sup>p. 44</sup>
 
=== Gross financial debt and maturity breakdown as of December 31st31 st , 2025 ===
 
* (stacked bar) '''Gross financial debt''' (nominal basis):
* '''Debt gearing''' was 20.6% in FY24 and 22.3% in FY25 <sup>p. 32</sup>.
** '''FY24''': EUR 19.2bn total (Tier 1: EUR 4.8bn; Tier 2: EUR 10.8bn; Senior debt: EUR 3.5bn) <sup>p. 32</sup>
* (stacked bar) '''Gross financial debt''' (nominal debt):
** '''FY24FY25''': EUR 1920.2bn3bn total (Tier 1: EUR 4.8bn,6bn; Tier 2: EUR 1012.8bn,2bn; Senior debt: EUR 3.5bn) <sup>p. 32</sup>
** '''FY25Jan 1st 2026''' (End of the grandfathering period): EUR 20.3bn total (Tier 1: EUR 43.6bn,2bn; Tier 2: EUR 1211.2bn,3bn; Senior debt: EUR 35.5bn8bn, of which EUR 0.4bn redeemed in Jan 2026) <sup>p. 32</sup>
* '''Debt gearing''': 20.6% in FY24 to 22.3% in FY25 <sup>p. 32</sup>
** '''Jan 1st 2026''' (End of the grandfathering period): EUR 20.3bn total (Tier 1: EUR 3.2bn, Tier 2: EUR 11.3bn, Senior debt: EUR 5.8bn, of which EUR 0.4bn redeemed in Jan 2026) <sup>p. 32</sup>
* (stacked bar) '''Contractual maturity breakdown''':
** '''2028''': EUR 0.5bn (Senior debt) <sup>p. 32</sup>
** '''2030''': EUR 0.9bn total (Tier 2: EUR 0.7bn,; Senior debt: EUR 0.2bn) <sup>p. 32</sup>
*** '''o/w Grandfathered debt''': Tier 2: EUR 0.7bn <sup>p. 32</sup>
** '''2031-2039''': EUR 1.5bn (Senior debt) <sup>p. 32</sup>
** '''≥2040''': EUR 11.3bn total (Tier 2: EUR 10.8bn,; Senior debt: EUR 0.5bn) <sup>p. 32</sup>
*** '''o/w Grandfathered debt''': Tier 2: EUR 0.2bn <sup>p. 32</sup>
** '''Undated''': EUR 5.3bn total (Tier 1: EUR 4.6bn,; Tier 2: EUR 0.7bn) <sup>p. 32</sup>
*** '''o/w Grandfathered debt''': Tier 1: EUR 1.4bn <sup>p. 32</sup>
* (stacked bar) '''Economic maturity breakdown''' (taking into account the first date of step up calls on institutionally placed subordinated debt):
** '''2026''': EUR 0.1bn (Tier 1) <sup>p. 32</sup>
*** '''o/w Grandfathered debt''': Tier 1: EUR 0.1bn <sup>p. 32</sup>
** '''2027''': EUR 2.4bn (Tier 2) <sup>p. 32</sup>
** '''2028''': EUR 0.6bn total (Tier 1: EUR 0.1bn,; Senior debt: EUR 0.5bn) <sup>p. 32</sup>
*** '''o/w Grandfathered debt''': Tier 1: EUR 0.1bn <sup>p. 32</sup>
** '''2029''': EUR 2.0bn (Tier 2) <sup>p. 32</sup>
** '''2030''': EUR 0.9bn total (Tier 2: EUR 0.7bn,; Senior debt: EUR 0.2bn) <sup>p. 32</sup>
*** '''o/w Grandfathered debt''': Tier 2: EUR 0.7bn <sup>p. 32</sup>
** '''2031-2039''': EUR 18.5bn3bn total (Tier 1: EUR 0.4bn,; Tier 2: EUR 6.4bn,; Senior debt: EUR 1.5bn) <sup>p. 32</sup>
*** '''o/w Grandfathered debt''': Tier 1: EUR 0.4bn <sup>p. 32</sup>
** '''≥2040''': EUR 0.5bn (Senior debt) <sup>p. 32</sup>
*** '''o/w Grandfathered debt''': Tier 2: EUR 0.2bn <sup>p. 32</sup>
** '''Undated''': EUR 4.7bn total (Tier 1: EUR 4.0bn,; Tier 2: EUR 0.7bn) <sup>p. 32</sup>
*** '''o/w Grandfathered debt''': Tier 1: EUR 0.8bn <sup>p. 32</sup>
* '''Subsequent events''': In January 2026, AXA called the remaining Tier 2 grandfathered GBP 139m due 2054 callable 2034 (5.625% issued January 2014,) and the Tier 1 grandfathered EUR 250m perpetual callable 2010 floating issued January 2005 <sup>p. 32</sup>.
* '''Economic maturity methodology''': Economic maturity takes into account the first date of step-up calls on institutionally placed subordinated debt; for Solvency II RT1 debt with no step-up, the undated nature of the instrument is retained <sup>p. 32</sup>.
 
=== General Account investedInvested assetsAssets ===
 
* (donut) '''Total General Account''' invested assets: EUR 450bn with a duration gap at -0.4 year <sup>p. 33</sup>
* '''Total Insurance Invested''' assets: EUR 450bn (100%) <sup>p. 33</sup>
** '''Fixed income''': EUR 345bn (77%) <sup>p. 33</sup>
*** '''Government bonds''': EUR 167bn (37%) <sup>p. 33</sup>
*** '''Corporate bonds''' and loans: EUR 121bn (27%) <sup>p. 33</sup>
*** '''Other fixed income''': EUR 56bn (13%), including Asset Backed Securities of EUR 25bn, Residential Loans of EUR 16bn, Commercial & Agricultural Loans of EUR 7bn, and Agency Pools of EUR 8bn <sup>p. 33</sup>
** '''Real estate''': EUR 41bn (9%) <sup>p. 33</sup>
** '''Infrastructure equity''': EUR 10bn (2%) <sup>p. 33</sup>
** '''Listed equities''': EUR 10bn (2%), including hedges; listed equities excluding hedges at EUR 14bn <sup>p. 33</sup>
** '''Private equity''' and hedge funds: EUR 23bn (5%), including Private Equity of EUR 17bn, Hedge Funds of EUR 5bn, and Non-listed Equities of EUR 1bn <sup>p. 33</sup>
** '''Cash''': EUR 19bn (4%) <sup>p. 33</sup>
** '''Policy loans''': EUR 2bn (0%) <sup>p. 33</sup>
 
=== Structured and Private Credit assets ===
 
* '''Residential mortgages''': EUR 16bn (4% of total G/A portfolio); includes EUR 6bn Dutch mortgages (NHG guaranteed) and EUR 10bn self-originated mortgages in Switzerland (56% LTV) and Germany (45% LTV) <sup>p. 34</sup>.
* '''CLO & ABS''': EUR 25bn (6% of total G/A portfolio); 91% senior CLOs with circa 40% subordination, with 100% rated AAA-A and 92% rated AAA-AA <sup>p. 34</sup>.
* '''Infrastructure debt''': EUR 8bn (2% of total G/A portfolio); skewed towards resilient industries including Telecom, Utilities, and Transport <sup>p. 34</sup>.
* '''CRE debt''': EUR 8bn (2% of total G/A portfolio); strong sector diversification (mainly logistics, residential, and retail), mostly in Europe, and circa 60% LTV <sup>p. 34</sup>.
* '''Mid-Market lending''': EUR 10bn (2% of total G/A portfolio); strong diversification with EUR 8m average ticket, invested through SMAs with strict underwriting guidelines (senior secured, covenants, restrictions on asset sales, and sector allocation) <sup>p. 34</sup>.
* '''Other structured assets''': EUR 2bn (0% of total G/A portfolio) <sup>p. 34</sup>.
* '''Total structured assets''': EUR 69bn (15% of total G/A portfolio), of which 54% is participating <sup>p. 34</sup>.
 
=== Investment portfolio | Fixed Income reinvestment ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FixedFY25 incomeTotal reinvestmentGeneral Account invested assets breakdown <sup>p. 3533</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | Reinvestment asset mixValue
! class="col-s" style="text-align:right" | Reinvestment% yieldof total
|-
| style="text-align:left" | GovernmentFixed bonds & relatedincome
| style="text-align:right" | 32%345
| style="text-align:right" | 77%
|-
| style="text-align:left" | InvestmentGovernment grade creditbonds
| style="text-align:right" | 40%167
| style="text-align:right" | 37%
|-
| style="text-align:left" | ABS/CLO/IGCorporate fundbonds financingand loans
| style="text-align:right" | 21%121
| style="text-align:right" | 27%
|-
| style="text-align:left" | BelowOther investmentfixed grade creditincome
| style="text-align:right" | 7%56
| style="text-align:right" | 13%
|-
| style="text-align:left" | PublicReal fixed incomeestate
| style="text-align:right" | 41
| style="text-align:right" | 3.59%
|-
| style="text-align:left" | PrivateInfrastructure & Structured fixed incomeequity
| style="text-align:right" | 10
| style="text-align:right" | 4.72%
|-
| style="text-align:left; font-weight:bold" | Total fixedListed incomeequities
| style="text-align:right; font-weight:bold" | 10
| style="text-align:right; font-weight:bold" | 3.92%
|-
| style="text-align:left" | Private equity and hedge funds
| style="text-align:right" | 23
| style="text-align:right" | 5%
|-
| style="text-align:left" | Cash
| style="text-align:right" | 19
| style="text-align:right" | 4%
|-
| style="text-align:left" | Policy loans
| style="text-align:right" | 2
| style="text-align:right" | 0%
|-
| style="text-align:left" | '''Total Insurance Invested Assets'''
| style="text-align:right" | '''450'''
| style="text-align:right" | '''100%'''
|}
</div>
 
* FixedTotal incomeGeneral reinvestmentAccount totaledinvested assets EUR 57bn450bn infor FY25.
* Duration gap at -0.4 year
* Reinvestment duration averaged 9 years.
* Invested assets portfolio breakdown (reported in EUR billion):
* Private & Structured credit reinvestment reached EUR 19.7bn at a yield of 4.7%, covering CLOs, ABS, infrastructure & CRE debt, fund financing, and private high yield.
* Other fixed income includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn), and Agency Pools (EUR 8bn)
* Strategic asset allocation reflects a gradual shift from alternative total return assets to private & structured credit.
* Listed equities includes hedges, with listed equities excluding hedges at EUR 14bn
* Private equity and hedge funds includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn), and Non-listed Equities (EUR 1bn)
 
=== Structured and Private Credit assets ===
* '''Table of contents''' section divider <sup>p. 36</sup>:
** 1. Debt and Invested Assets <sup>p. 31</sup>
** 2. '''Additional P&C disclosures''' <sup>p. 36</sup>
** 3. Additional IFRS17 disclosures <sup>p. 41</sup>
** 4. Sustainability <sup>p. 44</sup>
 
=== AXA XL Insurance | Large Commercial & Specialty business ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ AXAStructured XLand Insuranceprivate FY25 GWP by line of business andcredit geographyassets <sup>p. 3734</sup>
! style="text-align:left" | USDEUR billion unless otherwise mentioned
! class="col-ms" style="text-align:right" | Line of businessValue
! class="col-ms" style="text-align:right" | Share% of total G/A portfolio
! class="col-m" style="text-align:right" | Geography
! class="col-m" style="text-align:right" | Share
|-
| style="text-align:left; font-weight:bold" | Total structured and private credit assets
| class="col-m" style="text-align:right; font-weight:bold" | 1969
| class="col-m" style="text-align:right; font-weight:bold" | 15%
| class="col-m" style="text-align:right; font-weight:bold" | 19
| class="col-m" style="text-align:right; font-weight:bold" | —
|-
| style="text-align:left" | Residential mortgages
| class="col-m" style="text-align:right" | Casualty16
| class="col-m" style="text-align:right" | 354%
| class="col-m" style="text-align:right" | Americas
| class="col-m" style="text-align:right" | 46%
|-
| style="text-align:left" | CLO & ABS
| class="col-m" style="text-align:right" | Property25
| class="col-m" style="text-align:right" | 296%
| class="col-m" style="text-align:right" | Europe & APAC
| class="col-m" style="text-align:right" | 35%
|-
| style="text-align:left" | Infrastructure debt
| class="col-m" style="text-align:right" | Specialty8
| class="col-m" style="text-align:right" | 192%
| class="col-m" style="text-align:right" | UK & Lloyds
| class="col-m" style="text-align:right" | 19%
|-
| style="text-align:left" | CRE debt
| class="col-m" style="text-align:right" | Professional lines (including Cyber)8
| class="col-m" style="text-align:right" | 172%
|-
| class="col-m" style="text-align:right" | —
| class="col-m" style="text-align:rightleft" | Mid-market lending
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" | Other structured assets
| style="text-align:right" | 2
| style="text-align:right" | 0%
|}
</div>
 
* Total structured and private credit assets with 54% participating
* AXA XL Insurance is well diversified across lines of business and geographies, holding leading market positions across lines.
* Residential mortgages:
* Market leadership positions include Top 3 globally in:
* Includes EUR 6bn Dutch mortgages, NHG guaranteed.
** Multinational Programs
* Includes EUR 10bn self-originated mortgages in Switzerland (56% LTV) and Germany (45% LTV).
** Marine
* CLO & ABS: 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA).
** Fine Art & Specie
* Infrastructure debt: skewed towards resilient industries including telecom, utilities, and transport.
* (bubble) Managing the cycle to deliver consistent profitability (Profitability vs Ex-price growth %):
* CRE debt: showing strong sector diversification (mainly logistics, residential, and retail), mostly in Europe, and circa 60% LTV.
** Property: Highest profitability and highest ex-price growth
* Mid-market lending: featuring strong diversification with EUR 8m average ticket size; investments made through SMAs with strict underwriting guidelines (senior secured, covenants, restrictions on asset sales and sector allocation).
** Specialty: Medium profitability and medium ex-price growth
** Casualty: Medium-low profitability and medium-low ex-price growth
** Professional lines: Lowest profitability and lowest ex-price growth
 
=== P&CInvestment portfolio | FocusFixed onIncome Reservesreinvestment ===
 
* '''Fixed income reinvestment''' totaled EUR 57bn in FY25 <sup>p. 35</sup>.
* (donut) '''FY25 Fixed Income Reinvestment''' asset allocation:
** Government bonds & related: 32% (average rating: AA) <sup>p. 35</sup>
** Investment grade credit: 40% (average rating: A) <sup>p. 35</sup>
** ABS/CLO/IG fund financing: 21% <sup>p. 35</sup>
** Below investment grade credit: 7% <sup>p. 35</sup>
* (bar) '''FY25 Fixed Income Reinvestment Yield''':
** Public fixed income (government and corporate bonds and related): 3.5% <sup>p. 35</sup>
** Private & Structured fixed income (CLOs, ABS, Infra & CRE debt, Fund financing and Private hybrid): 4.7% <sup>p. 35</sup>
** Total fixed income: 3.9% <sup>p. 35</sup>
* '''Reinvestment yield''' achieved at 3.9% on EUR 57bn invested <sup>p. 35</sup>:
** '''Average duration''' of 9 years <sup>p. 35</sup>
** Includes EUR 19.7bn of Private & Structured Credit invested at 4.7% (CLOs, ABS, Infra & CRE debt, Fund financing and Private HY) <sup>p. 35</sup>
** Gradual shift from alternative total return assets to Private & Structured credit <sup>p. 35</sup>
 
=== Table of contents ===
 
* '''Table of contents''' agenda overview:
** 1. Debt and Invested Assets <sup>p. 31</sup>
** '''2. Additional P&C disclosures''' (active section) <sup>p. 36</sup>
** 3. Additional IFRS17 disclosures <sup>p. 41</sup>
** 4. Sustainability <sup>p. 44</sup>
 
=== AXA XL Insurance | Large Commercial & Specialty business ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ClaimsAXA reservesXL ratioInsurance andFY25 Technical reserves ratioGWP <sup>p. 3837</sup>
! style="text-align:left" | RatioUSD billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY18GWP by line of business
! class="col-s" style="text-align:right" | FY19GWP by geography
! class="col-s" style="text-align:right" | FY20
! class="col-s" style="text-align:right" | FY21
! class="col-s" style="text-align:right" | FY22
! class="col-s" style="text-align:right" | FY23
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left; font-weight:bold" | Claims reserves ratio (IFRS4)Total
| style="text-align:right; font-weight:bold" | 179%19
| style="text-align:right; font-weight:bold" | 185%19
|-
| style="text-align:right" | 193%
| style="text-align:rightleft" | 188%'''Line of business'''
| style="text-align:right" | 189%
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Casualty
| style="text-align:right" | 35%
| style="text-align:right" | —
|-
| style="text-align:left" | Claims reserves ratio (IFRS17)Property
| style="text-align:right" | 29%
| style="text-align:right" | —
|-
| style="text-align:left" | Specialty
| style="text-align:right" | 19%
| style="text-align:right" | —
|-
| style="text-align:left" | Professional lines (including Cyber)
| style="text-align:right" | 17%
| style="text-align:right" | —
| style="text-align:right" | 198%
| style="text-align:right" | 195%
| style="text-align:right" | 180%
| style="text-align:right" | 175%
|-
| style="text-align:left" | Technical reserves ratio (IFRS4)'''Geography'''
| style="text-align:right" | 213%
| style="text-align:right" | 227%
| style="text-align:right" | 233%
| style="text-align:right" | 226%
| style="text-align:right" | 227%
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Americas
| style="text-align:right" | —
| style="text-align:right" | 46%
|-
| style="text-align:left" | TechnicalEurope reserves& ratio (IFRS17)APAC
| style="text-align:right" | —
| style="text-align:right" | 35%
|-
| style="text-align:left" | UK & Lloyds
| style="text-align:right" | —
| style="text-align:right" | 19%
| style="text-align:right" | —
| style="text-align:right" | 234%
| style="text-align:right" | 232%
| style="text-align:right" | 216%
| style="text-align:right" | 210%
|}
</div>
 
* '''AXA XL Insurance''' is well diversified across lines of business and geographies, holding leading market positions across lines.
* Technical reserves ratio includes net undiscounted claims reserves and unearned premium reserves.
* '''Leading market positions''' globally, ranking Top 3 in:
** Multinational Programs
** Marine
** Fine Art & Specie
* (bubble chart) '''Managing the cycle''' to deliver consistent profitability (Profitability vs Ex-price growth):
** '''Property''': High profitability, high ex-price growth
** '''Specialty''': Medium profitability, medium-high ex-price growth
** '''Casualty''': Medium-low profitability, medium ex-price growth
** '''Professional lines''': Low profitability, low ex-price growth
 
=== P&C | Focus on Reserves ===
 
* (bar chart) '''Claims reserves ratio''' (Net undiscounted claims reserves / Net earned premiums) <sup>p. 38</sup>:
** '''IFRS4''': FY18 179%, FY19 185%, FY20 193%, FY21 188%, FY22 189% <sup>p. 38</sup>
** '''IFRS17''': FY22 198%, FY23 195%, FY24 180%, FY25 175% <sup>p. 38</sup>
* (bar chart) '''Technical reserves ratio''' (Net undiscounted technical reserves / Net earned premiums) <sup>p. 38</sup>:
** '''IFRS4''': FY18 213%, FY19 227%, FY20 233%, FY21 226%, FY22 227% <sup>p. 38</sup>
** '''IFRS17''': FY22 234%, FY23 232%, FY24 216%, FY25 210% <sup>p. 38</sup>
* '''Technical reserves''' include net undiscounted claims reserves and unearned premium reserves <sup>p. 38</sup>.
 
=== P&C | 2026 Simplified Group Nat Cat Reinsurance Program 1 ===
Line 1,100 ⟶ 1,250:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Insurance segment (occurrence protection) capacity and retention by peril <sup>p. 39</sup>
! style="text-align:left" | PerilEUR billion
! class="col-s" style="text-align:right" | Capacity (EUR billion)
! class="col-s" style="text-align:right" | Retention (EUR)
|-
| style="text-align:left" | EU Windstorm
Line 1,125 ⟶ 1,275:
| style="text-align:right" | 600m
|-
| style="text-align:left" | OtherPer other perils
| style="text-align:right" | —
| style="text-align:right" | 400m
|}
</div>
* Retention levels remained stable in 2026 compared to 2025 <sup>p. 39</sup>.
* NA Hurricane: varying retention between EUR 400m MX and EUR 600m NA <sup>p. 39</sup>
* NA Earthquake: varying retention between EUR 400m MX and EUR 600m NA <sup>p. 39</sup>
* Per other perils: capacity varies by peril type; other perils include Turkey earthquake, Other Europe and NA perils, South America Earthquake, and other secondary perils <sup>p. 39</sup>
* (diagram) Reinsurance segment (illustrative) utilizes Alternative Capital & Cat Bonds <sup>p. 39</sup>.
 
=== P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026 ===
* Retention levels stable in 2026 compared to 2025.
* Reinsurance segment utilizes alternative capital and cat bonds.
* Program excludes local reinsurance covers.
 
=== P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026 ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Group underlying earnings deviation to average Nat Cat charges in 2026 (net of reinsurance, post-tax) <sup>p. 40</sup>
! style="text-align:left" | Percentile
! class="col-s" style="text-align:right" | Deviation (EUR billion)
|-
| style="text-align:left" | 1/20y (95th percentile (1/20y)
| style="text-align:right" | -1.2
|-
| style="text-align:left" | 1/10y (90th percentile (1/10y)
| style="text-align:right" | -0.8
|-
| style="text-align:left" | 1/5y (80th percentile (1/5y)
| style="text-align:right" | -0.4
|-
| style="text-align:left" | Median (50th percentile (Median)
| style="text-align:right" | +0.1
|-
| style="text-align:left" | 1/5y (20th percentile (1/5y)
| style="text-align:right" | +0.5
|-
| style="text-align:left" | 1/10y (10th percentile (1/10y)
| style="text-align:right" | +0.7
|-
| style="text-align:left" | 1/20y (5th percentile (1/20y)
| style="text-align:right" | +0.8
|}
Line 1,169 ⟶ 1,320:
{| class="wikitable"
|+ Average expected Nat Cat charges net of reinsurance, pre-tax <sup>p. 40</sup>
! style="text-align:left" | YearEUR billion
! class="col-sxs" style="text-align:right" | Expected charges2025
! class="col-sxs" style="text-align:right" | Estimated impact on GEP2026
|-
| style="text-align:left" | FY25Average expected Nat Cat charges
| class="col-sxs" style="text-align:right" | 2.6
| class="col-sxs" style="text-align:right" | ca2. 4.5%7
|-
| style="text-align:left" | FY26Estimated impact on GEP
| class="col-sxs" style="text-align:right" | 2ca.7 4.5%
| class="col-sxs" style="text-align:right" | ca. 4.5%
|}
</div>
* Earnings deviation basis: Group underlying earnings deviation to average Nat Cat charges in 2026 net of reinsurance, post-tax, in EUR billion <sup>p. 40</sup>.
* More severe years (negative deviation in ca. 40% of cases) <sup>p. 40</sup>:
* Less severe years (positive deviation in ca. 60% of cases) <sup>p. 40</sup>:
* Nat Cat definition: Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance <sup>p. 40</sup>.
* Deviation baseline: Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year, representing ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance <sup>p. 40</sup>.
 
=== Table of contents ===
* Earnings deviation analysis presented in EUR billion, net of reinsurance.
* More severe years result in negative deviation in ca. 40% of cases.
* Less severe years result in positive deviation in ca. 60% of cases.
* Natural catastrophe cost is defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance.
* Deviation comparison is made to a normalized level, representing costs associated with natural catastrophes expected in an average year, which is ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance.
 
* '''Table of contents''' section divider <sup>p. 41</sup>:
<div style="overflow-x:auto">
** 1. Debt and Invested Assets <sup>p. 31</sup>
{| class="wikitable fintable"
|+** Table of2. contentsAdditional sectionP&C navigationdisclosures <sup>p. 4136</sup>
** '''3. Additional IFRS17 disclosures''' <sup>p. 41</sup>
! style="text-align:left" | Section
** 4. Sustainability <sup>p. 44</sup>
! class="col-s" style="text-align:right" | Page
|-
| style="text-align:left" | 1. Debt and Invested Assets
| style="text-align:right" | 31
|-
| style="text-align:left" | 2. Additional P&C disclosures
| style="text-align:right" | 36
|-
| style="text-align:left" | 3. Additional IFRS17 disclosures
| style="text-align:right" | 41
|-
| style="text-align:left" | 4. Sustainability
| style="text-align:right" | 44
|}
</div>
 
=== P&C | Margin analysisAnalysis ===
 
* (flow) '''P&C Margin Analysis''' (in EUR million pre-tax, changes versus FY24 at constant FX) <sup>p. 42</sup>:
<div style="overflow-x:auto">
** '''Technical Result''' components:
{| class="wikitable fintable"
|+*** P&C'''Current Accident Year Undiscounted Technical Margin''': AnalysisEUR 2,778m (pre-taxchange: unless specified+EUR otherwise707m) <sup>p. 42</sup>
**** Gross Earned Premiums: EUR 57,656m (+6%) <sup>p. 42</sup>
! style="text-align:left" | EUR million unless otherwise mentioned
**** Current Accident Year Undiscounted Combined Ratio: 95.2% (-1.0pt) <sup>p. 42</sup>
! class="col-s" style="text-align:right" | Value
**** ''o/w Nat Cats'': 3.4% (-0.4pt) <sup>p. 42</sup>
! class="col-s" style="text-align:right" | Change
*** '''Current Accident Year Discounting''': EUR 2,009m (change: +EUR 115m) <sup>p. 42</sup>
|-
**** Discounting Ratio (in Combined Ratio points): -3.5% (+0.0pt) <sup>p. 42</sup>
| style="text-align:left" | Current Accident Year Undiscounted Technical Margin
**** Current Accident Year Net Claims reserves: EUR 19.0bn <sup>p. 42</sup>
| style="text-align:right" | 2,778
**** Duration: 4.0 years <sup>p. 42</sup>
| style="text-align:right" | +707
**** Current Accident Year Discount rate: 2.8% <sup>p. 42</sup>
|-
*** '''Prior Years' Reserve Development (PYD)''': EUR 622m (change: -EUR 341m) <sup>p. 42</sup>
| style="text-align:left" | Gross Earned Premiums
**** PYD ratio: -1.1% (+0.7pt) <sup>p. 42</sup>
| style="text-align:right" | 57,656
** '''Financial Result''' components:
| style="text-align:right" | +6%
*** '''Investment Income''': EUR 3,988m (change: +EUR 435m) <sup>p. 42</sup>
|-
**** FY25 Average Assets: EUR 115bn <sup>p. 42</sup>
| style="text-align:left" | Current Accident Year Undiscounted Combined Ratio
**** Asset book yield: 3.5% <sup>p. 42</sup>
| style="text-align:right" | 95.2%
**** FY25 Reinvestment yield (on fixed income assets): 4.3% <sup>p. 42</sup>
| style="text-align:right" | -1.0pt
*** '''Insurance Finance Expenses''': -EUR 1,358m (change: -EUR 235m) <sup>p. 42</sup>
|-
**** FY24 Reserves at locked-in rate: EUR 71bn <sup>p. 42</sup>
| style="text-align:left; padding-left:1.5em" | o/w Nat Cats
**** Liability book yield: 1.9% <sup>p. 42</sup>
| style="text-align:right" | 3.4%
** '''Underlying Earnings before tax''': EUR 8,040m (change: +EUR 681m) <sup>p. 42</sup>
| style="text-align:right" | -0.4pt
*** Tax: -EUR 2,060m (change: -EUR 169m) <sup>p. 42</sup>
|-
*** Affiliates, Minority interests & Other: -EUR 108m (change: -EUR 10m) <sup>p. 42</sup>
| style="text-align:left" | Current Accident Year Discounting
*** '''Underlying Earnings''': EUR 5,872m (change: +EUR 501m, +9% growth vs. FY24 at constant FX) <sup>p. 42</sup>
| style="text-align:right" | 2,009
* '''FY25 sensitivity''' to Current Accident Year discount rate changes (parallel shift of the full-year average yield curve used for discounting FY25 current accident year net reserve) <sup>p. 42</sup>:
| style="text-align:right" | +115
** +25bps: +EUR 0.2bn <sup>p. 42</sup>
|-
** -25bps: -EUR 0.2bn <sup>p. 42</sup>
| style="text-align:left" | Discounting Ratio (in Combined Ratio points)
* '''2026e Insurance Finance Expenses''' (pre-tax): ~ -EUR 1.4bn <sup>p. 42</sup>
| style="text-align:right" | -3.5%
** Sensitivity of 2026e Insurance Finance Expenses to changes in 2025 current AY Discount <sup>p. 42</sup>:
| style="text-align:right" | +0.0pt
*** +25bps: ~ -EUR 50m <sup>p. 42</sup>
|-
*** -25bps: ~ +EUR 50m <sup>p. 42</sup>
| style="text-align:left" | Current Accident Year Net Claims reserves
| style="text-align:right" | 19.0bn
| style="text-align:right" | —
|-
| style="text-align:left" | Duration
| style="text-align:right" | 4.0 years
| style="text-align:right" | —
|-
| style="text-align:left" | Current Accident Year Discount rate
| style="text-align:right" | 2.8%
| style="text-align:right" | —
|-
| style="text-align:left" | Prior Years' Reserve Development (PYD)
| style="text-align:right" | 622
| style="text-align:right" | -341
|-
| style="text-align:left" | PYD ratio
| style="text-align:right" | -1.1%
| style="text-align:right" | +0.7pt
|-
| style="text-align:left" | Investment Income
| style="text-align:right" | 3,988
| style="text-align:right" | +435
|-
| style="text-align:left" | FY25 Average Assets
| style="text-align:right" | 115bn
| style="text-align:right" | —
|-
| style="text-align:left" | Asset book yield
| style="text-align:right" | 3.5%
| style="text-align:right" | —
|-
| style="text-align:left" | FY25 Reinvestment yield (on fixed income assets)
| style="text-align:right" | 4.3%
| style="text-align:right" | —
|-
| style="text-align:left" | Insurance Finance Expenses
| style="text-align:right" | -1,358
| style="text-align:right" | -235
|-
| style="text-align:left" | FY24 Reserves at locked-in rate
| style="text-align:right" | 71bn
| style="text-align:right" | —
|-
| style="text-align:left" | Liability book yield
| style="text-align:right" | 1.9%
| style="text-align:right" | —
|-
| style="text-align:left" | Underlying Earnings before tax
| style="text-align:right" | 8,040
| style="text-align:right" | +681
|-
| style="text-align:left" | Tax
| style="text-align:right" | -2,060
| style="text-align:right" | -169
|-
| style="text-align:left" | Affiliates, Minority interests & Other
| style="text-align:right" | -108
| style="text-align:right" | -10
|-
| style="text-align:left" | Underlying Earnings
| style="text-align:right" | 5,872
| style="text-align:right" | +501
|}
</div>
 
=== L&H | Margin Analysis ===
* Underlying Earnings representing +9% growth vs. FY24 at constant FX
 
* '''L&H Margin Analysis''' includes scope impact; changes are versus FY24 at constant FX <sup>p. 43</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 sensitivity to Current Accident Year discount rate changes <sup>p. 42</sup>
! style="text-align:left" | Change in discount rate
! class="col-s" style="text-align:right" | Impact (EUR billion)
|-
| style="text-align:left" | +25bps
| style="text-align:right" | +0.2
|-
| style="text-align:left" | -25bps
| style="text-align:right" | -0.2
|}
</div>
 
=== Technical Result (in EUR million, pre-tax) ===
<div style="overflow-x:auto">
{| class="wikitable"
|+ 2026e Insurance Finance Expenses (pre-tax) <sup>p. 42</sup>
! style="text-align:left" | Item
! class="col-s" style="text-align:right" | Value
|-
| style="text-align:left" | 2026e Insurance Finance Expenses
| class="col-s" style="text-align:right" | ~ -1.4bn
|-
| style="text-align:left" | Sensitivity to changes in 2025 current AY Discount (+25bps)
| class="col-s" style="text-align:right" | ~ -50m
|-
| style="text-align:left" | Sensitivity to changes in 2025 current AY Discount (-25bps)
| class="col-s" style="text-align:right" | ~ +50m
|}
</div>
 
=== L&H | Margin analysis ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ L&HTechnical Margin, AnalysisFY25 (LFL)vs FY24 <sup>p. 43</sup>
! style="text-align:left" | EUR million unless otherwise mentioned
! class="col-s" style="text-align:right" | FY25
! class="col-ms" style="text-align:right" | Change LFL
|-
| style="text-align:left" | Short-term Technical Margin
Line 1,354 ⟶ 1,399:
| style="text-align:right" | +60
|-
| style="text-align:left" | Gross earnedEarned premiumsPremiums
| style="text-align:right" | 17,416
| style="text-align:right" | +10%
|-
| style="text-align:left" | Combined ratioRatio (all year)
| style="text-align:right" | 97.2%
| style="text-align:right" | improved -0.1pt1pts
|-
| style="text-align:left" | Long-term Technical Margin
Line 1,373 ⟶ 1,418:
| style="text-align:right" | -150
| style="text-align:right" | -58
|}
</div>
* Short-term Technical Margin includes the recapture of Laya.
 
=== Financial Result (in EUR million, pre-tax) ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Investment Income and Insurance Finance Expenses, non-VFA <sup>p. 43</sup>
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" | Value
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Investment Income
| style="text-align:right" | 2,484
| style="text-align:right" | -1
|-
| style="text-align:left" | Average assets
| style="text-align:right" | 98bn
| style="text-align:right" | —
|-
| style="text-align:left" | Asset book yield
| style="text-align:right" | 2.5%
| style="text-align:right" | —
|-
| style="text-align:left" | Reinvestment yield
| style="text-align:right" | 3.8%
| style="text-align:right" | —
|-
| style="text-align:left" | Insurance Finance Expenses
| style="text-align:right" | -1,538
| style="text-align:right" | -9
|-}
</div>
| style="text-align:left" | Reserves
* Average Assets (FY25) were EUR 98bn.
| style="text-align:right" | 62bn
* Asset book yield was 2.5%.
| style="text-align:right" | —
* Reinvestment yield (FY25 on fixed income assets) was 3.8%.
|-
* Reserves at locked-in rate (FY24) were EUR 62bn.
| style="text-align:left" | Liability book yield
* Liability book yield was 2.5%.
| style="text-align:right" | 2.5%
 
| style="text-align:right" | —
=== Earnings Bridge ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying Earnings walk <sup>p. 43</sup>
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" | Value
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Underlying Earnings before tax
Line 1,410 ⟶ 1,463:
| style="text-align:right" | +65
|-
| style="text-align:left" | Affiliates and minorities (including other)
| style="text-align:right" | 72
| style="text-align:right" | -51
Line 1,419 ⟶ 1,472:
|}
</div>
* Underlying Earnings represents +7% growth versus FY24 at constant FX.
 
=== Life & Health FY25 CSM Key Sensitivities (in EUR billion) ===
* L&H margin analysis includes scope impact
* Underlying Earnings representing +7% growth vs. FY24 at constant FX
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Life & Health FY25 CSM sensitivitiesSensitivity <sup>p. 43</sup>
! style="text-align:left" | CSMEUR Sensitivitybillion unless otherwise mentioned
! class="col-s" style="text-align:right" | Impact+50bps (EUR/ billion)+25%
! class="col-s" style="text-align:right" | -50bps / -25%
|-
| style="text-align:left" | Baseline CSM Baseline
| style="text-align:right" | 33.3
| style="text-align:right" | —
|-
| style="text-align:left" | Interest ratesrate +50bpssensitivity
| style="text-align:right" | -0.8
|-
| style="text-align:left" | Interest rates -50bps
| style="text-align:right" | +0.6
|-
| style="text-align:left" | Sovereign spreadsspread +50bpssensitivity
| style="text-align:right" | -1.9
|-
| style="text-align:left" | Sovereign spreads -50bps
| style="text-align:right" | +1.9
|-
| style="text-align:left" | Corporate spread +50bpssensitivity
| style="text-align:right" | -0.8
|-
| style="text-align:left" | Corporate spread -50bps
| style="text-align:right" | +0.7
|-
| style="text-align:left" | EquitiesEquity +25%sensitivity
| style="text-align:right" | +1.8
|-
| style="text-align:left" | Equities -25%
| style="text-align:right" | -2.2
|}
</div>
 
*=== '''Table of contents''' navigation menu <sup>p. 44</sup>:===
 
* '''Table of contents''' section navigation:
** 1. Debt and Invested Assets <sup>p. 31</sup>
** 2. Additional P&C disclosures <sup>p. 36</sup>
Line 1,466 ⟶ 1,515:
=== Expanding AXA's role in society: AXA for Progress Index 1 ===
 
<div style="overflow-x:auto">
* '''As a Global Investor''':
{| class="wikitable"
** '''Climate transition financing''': Target of EUR 5.0bn² per year vs. 2025 Result of EUR 6.4bn <sup>p. 45</sup>
|+ AXA for Progress Index performance dashboard <sup>p. 45</sup>
** '''Community resilience financing''': Target of >EUR 500m² per year vs. 2025 Result of EUR 1.4bn <sup>p. 45</sup>
! style="text-align:left" | Pillar
* '''As a Global Insurer''':
! class="col-m" style="text-align:right" | Metric
** '''Transition underwriting''': Target of EUR 6.0bn³ in P&C GWP (cumulative 2024-2026) vs. 2025 Result of EUR 4.6bn <sup>p. 45</sup>
! class="col-m" style="text-align:right" | Target
** '''Climate adaptation solutions''': Target of >20,000⁴ solutions & services (cumulative 2024-2026, target revised in 2025) vs. 2025 Result of 19,698 (cumulative 2024-2025) <sup>p. 45</sup>
! class="col-m" style="text-align:right" | 2025 Result
** '''Inclusive insurance''': Target of >20m⁵ customers by 2026 vs. 2025 Result of 20.6m <sup>p. 45</sup>
|-
* '''As a Company''':
| style="text-align:left" | Global Investor
** '''Employee climate training''': Target of >80,000⁶ AXA Group employees trained on climate adaptation by 2026 vs. 2025 Result of 46,420 <sup>p. 45</sup>
| class="col-m" style="text-align:right" | Climate transition financing
** '''Net-Zero contribution''': Target of -50%⁷ by 2030 in absolute carbon emissions and offset of residual emissions⁸ vs. 2025 Result of -64% reduction against 2019 <sup>p. 45</sup>
| class="col-m" style="text-align:right" | EUR 5.0bn per year
** '''Employee volunteering''': Target of 50% of AXA Group employees engaged in volunteering activities by 2026 vs. 2025 Result of 56% <sup>p. 45</sup>
| class="col-m" style="text-align:right" | EUR 6.4bn
 
---|-
| style="text-align:left" | Global Investor
# AXA's Sustainability Statement is subject to completion of a certification with limited assurance by AXA Group's auditors and will be presented to the AXA Board of Directors for approval on March 11, 2026.
| class="col-m" style="text-align:right" | Community resilience financing
# Scope: corporate and sovereign debt, real estate and private assets. Timeframe: per annum through 2030.
| class="col-m" style="text-align:right" | >EUR 500m per year
# Scope: AXA France, AXA Germany, AXA Switzerland, AXA UK & Ireland, AXA Belgium, AXA Hong Kong, AXA Mexico, and AXA XL; Unit: Gross Written Premiums (GWP); Timeframe: cumulative 2024-2026.
| class="col-m" style="text-align:right" | EUR 1.4bn
# Scope: Commercial lines portfolio of AXA France, AXA Germany, AXA Switzerland, AXA UK, AXA Belgium, AXA Hong Kong, AXA Mexico, and AXA XL; Climate solutions & services include (i) training/education, (ii) risk assessment/awareness, (iii) gap analysis, (iv) prevention/adaptation solution, and/or (v) crisis management/remediation response. Timeframe: cumulative 2024-2026. Following strong support within the Group for climate adaptation solutions & services in 2024 and 2025, AXA is proposing a significant increase in its target for the 2024-2026 period, from >9,000 to >20,000.
|-
# Low-income to mass market segments in emerging markets and modest income segments in mature markets.
| style="text-align:left" | Global Insurer
# Number of employees who have been trained on climate change adaptation, completing a training under the AXA Sustainability Academy. Timeframe: cumulative 2024-2026.
| class="col-m" style="text-align:right" | Transition underwriting
# Variation of AXA Group absolute carbon emissions (scope: energy Scopes 1 and 2, car fleet and business travel). Timeframe: 2019-2030.
| class="col-m" style="text-align:right" | EUR 6.0bn in P&C GWP (cumulative 2024-2026)
# Carbon credits from projects that focus on capturing and storing carbon emissions from the atmosphere using nature-based or technical solutions (e.g. restorative agriculture, forest restoration or carbon capture and storage).
| class="col-m" style="text-align:right" | EUR 4.6bn
|-
| style="text-align:left" | Global Insurer
| class="col-m" style="text-align:right" | Climate adaptation solutions
| class="col-m" style="text-align:right" | >20,000 (cumulative 2024-2026)
| class="col-m" style="text-align:right" | 19,698
|-
| style="text-align:left" | Global Insurer
| class="col-m" style="text-align:right" | Inclusive insurance customers
| class="col-m" style="text-align:right" | >20m by 2026
| class="col-m" style="text-align:right" | 20.6m
|-
| style="text-align:left" | Company
| class="col-m" style="text-align:right" | Employee climate training
| class="col-m" style="text-align:right" | >80,000 by 2026
| class="col-m" style="text-align:right" | 46,420
|-
| style="text-align:left" | Company
| class="col-m" style="text-align:right" | Net-Zero contribution
| class="col-m" style="text-align:right" | -50% absolute carbon emissions by 2030
| class="col-m" style="text-align:right" | -64% reduction against 2019
|-
| style="text-align:left" | Company
| class="col-m" style="text-align:right" | Employee volunteering
| class="col-m" style="text-align:right" | 50% of employees by 2026
| class="col-m" style="text-align:right" | 56%
|}
</div>
* '''AXA for Progress Index''' performance dashboard across three pillars: Global Investor, Global Insurer, and Company <sup>p. 45</sup>.
* '''Climate adaptation solutions''': Target of >20,000 climate adaptation solutions & services (cumulative 2024-2026; target revised in 2025 from >9,000) vs. 19,698 cumulative 2024-2025 result <sup>p. 45</sup>.
* '''Net-Zero contribution''': Target of -50% absolute carbon emissions by 2030 (scope: energy Scopes 1 and 2, car fleet, and business travel; baseline 2019) and offset of residual emissions via nature-based or technical carbon capture projects vs. -64% reduction against 2019 in 2025 <sup>p. 45</sup>.
 
=== Sustainability Performance & Ratings ===
Line 1,492 ⟶ 1,572:
<div style="overflow-x:auto">
{| class="wikitable"
|+ AXA's ESG ratings and scores <sup>p. 46</sup>
! style="text-align:left" | Rating Agency
! class="col-m" style="text-align:right" | 2025 Score
|-
| style="text-align:left" | S&P Global
| class="col-m" style="text-align:right" | 97th percentile in Dow Jones Best-in-Class Europe & World indices
|-
| style="text-align:left" | MSCI
Line 1,509 ⟶ 1,589:
|-
| style="text-align:left" | FTSE Russell
| class="col-m" style="text-align:right" | 4.3/5 in FTSE4Good Index Series
|}
</div>
* CSA ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (specifically AXA Restricted Shares), with results as of February 6th, 2026
 
* '''FTSE Russell''' 2025 score: 4.3/5 in FTSE4Good Index Series <sup>p. 46</sup>
* The CSA ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (more precisely AXA Restricted Shares); results as of February 6th, 2026
 
=== Scope ===
 
* '''France''' scope includes insurance activities, banking activities, and holding <sup>p. 47</sup>.
* '''Europe''' scope includes Switzerland (insurance activities), Germany (insurance activities and holding), Belgium and LuxemburgLuxembourg (insurance activities and holding), United Kingdom and Ireland (insurance activities and holding), Spain (insurance activities and holdings), Italy (insurance activities), Prima (insurance activities), and AXA Life Europe (insurance activities) <sup>p. 47</sup>.
* '''AXA XL''' scope includes insurance and reinsurance activities and holding <sup>p. 47</sup>.
* '''Asia, Africa & EME-LATAM''' scope includes:
** '''Asia''': Japan (insurance activities and holding), Hong Kong (insurance activities), Thailand P&C, China P&C, South Korea, and Asia Holdings (all fully consolidated); China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S, and India (Life activities disposed on March 11, 2024 and holding) businesses (consolidated under equity method consolidated, contributing only to NBV, PVEP, underlying earnings, and net income) <sup>p. 47</sup>.
** '''Africa''': Morocco (insurance activities and holding), Nigeria (insurance activities and holding), and Egypt (insurance activities and holding) (all fully consolidated) <sup>p. 47</sup>.
** '''EME-LATAM''': Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding), and Türkiye (insurance activities and holding) (all fully consolidated); Russia (Reso) (insurance activities) (consolidated under equity method consolidated, contributing only to net income) <sup>p. 47</sup>.
** '''AXA Mediterranean Holdings''' <sup>p. 47</sup>.
* '''Transversal & Other''' scope includes AXA Assistance, AXA Liabilities Managers, AXA, and other Central Holdings <sup>p. 47</sup>.
* '''AXA Investment Managers''' (until July 1, 2025) scope includes AXA Investment Managers, Select (previously referred to as Architas), and Capza (all fully consolidated), and Asian joint ventures (consolidated under equity method consolidated) <sup>p. 47</sup>.
* '''Accounting standards''' note: Unlessunless otherwise specified, all comparative figures going back to 2023 are under IFRS17/9 standards effective January 1, 2023; periods prior to 2023 have not been restated and are presented under IFRS4 <sup>p. 47</sup>.
 
=== Glossary ===
Line 1,545 ⟶ 1,625:
* '''Underlying return on in-force''': represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance <sup>p. 48</sup>
 
=== February 26, 2026 Thank you Full Year 2025 earningsEarnings ===
 
* '''FullConcluding Yearslide 2025'''of earningsthe presentation concluding slide dated February 26, 2026 <sup>p. 49</sup>.
* '''Presentation title''': Full Year 2025 Earnings <sup>p. 49</sup>.
* '''Presentation date''': February 26, 2026 <sup>p. 49</sup>.
 
== Abbreviations ==
 
* '''AA''': SeniorityS&P rating from 'AA-' to 'AA+'
* '''AAA''': SeniorityS&P rating from 'AAA-' to 'AAA+'
* '''ABS''': Asset-Backed Securities
* '''AEP''': Aggregate Exceedance Probability
* '''AI''': Artificial Intelligence
* '''APAC''': Asia-Pacific
* '''APM''': Alternative Performance Measures
* '''AXA IM''': AXA Investment Managers
* '''AXA UKXL''': AXA UnitedXL, KingdomAXA's large property and casualty and specialty risk division
* '''AXA XL''': AXA XL (AXA's large property and casualty and specialty risk division)
* '''AY''': Accident Year
* '''BBA''': Beneficial Business AcquisitionBacking Annuities
* '''CDP''': Carbon Disclosure Project
* '''CLO''': Collateralized Loan Obligation
Line 1,568 ⟶ 1,650:
* '''CSM''': Contractual Service Margin
* '''CY''': Calendar Year
* '''DPS''': DividendDividends Per Share
* '''EME''': Europe,Emerging Middle EastMarkets
* '''EOF''': Eligible Own Funds
* '''EPS''': Earnings Per Share
Line 1,575 ⟶ 1,657:
* '''EU''': European Union
* '''EUR''': Euro
* '''FTSE''': Financial Times Stock Exchange
* '''FX''': Foreign Exchange
* '''GAAP''': Generally Accepted Accounting Principles
* '''GBP''': Great British Pound
* '''GEP''': Gross Earned Premium
* '''GWP''': Gross Written Premiums
* '''HKD''': Hong Kong Dollar
* '''HY''': High Yield
* '''IFE''': Insurance Finance Expenses
* '''IFRS''': International Financial Reporting Standards
Line 1,589 ⟶ 1,672:
* '''LTV''': Loan-to-Value
* '''MSCI''': Morgan Stanley Capital International
* '''MX''': Mexico
* '''NA''': North America
* '''NB CSM''': New Business Contractual Service Margin
* '''NBV''': New Business Value
* '''NHG''': Nationale Hypotheek Garantie (National Mortgage Guarantee)
* '''NPS''': Net Promoter Score
* '''OCI''': Other Comprehensive Income
* '''PAA''': ProportionatePolicyholder AmortizationAnnuity ApproachAssets
* '''PE''': Private Equity
* '''PVEP''': Present Value of Expected Profits
* '''PYD''': Prior Years' Reserve Development
* '''RCG''': ReplicatingReclassification Coreof GrowthGains
* '''ROE''': Return on Equity
* '''SCR''': Solvency Capital Requirement
Line 1,610 ⟶ 1,694:
* '''USD''': United States Dollar
* '''VAT''': Value Added Tax
* '''VFA''': Volatility Adjustment